Antiplatelet therapy: Personalized medicine for clopidogrel resistance?

Jean Sébastien Hulot, Valentin Fuster

Research output: Contribution to journalComment/debate

19 Scopus citations


The benefits of clopidogrel in the treatment and prevention of coronary artery disease vary among patients. Studies have identified predictive markers of poor response to clopidogrel that might allow risk stratification of patients. are we ready to enter the age of personalized medicine?

Original languageEnglish
Pages (from-to)334-336
Number of pages3
JournalNature Reviews Cardiology
Issue number5
StatePublished - May 2009


Dive into the research topics of 'Antiplatelet therapy: Personalized medicine for clopidogrel resistance?'. Together they form a unique fingerprint.

Cite this